One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor-Positive Early Breast Cancer?.
Cescon, David W. MD, PhD 1,; Kalinsky, Kevin MD 2,; DeMichele, Angela M. MD, MSCE 3,,
doi : 10.1200/JCO.22.01026
Volume 40(22) pgs. 2395-2514,e1-e2 August 1, 2022
Prenatal DNA Sequencing for Fetal Aneuploidy Also Detects Maternal Cancer: Importance of Timely Workup and Management in Pregnant Women.
Turriff, Amy E. ScM 1,; Annunziata, Christina M. MD, PhD 2,; Bianchi, Diana W. MD 1,3,
doi : 10.1200/JCO.22.00733
Yin and Yang of Psychological Health in the Cancer Experience: Does Positive Psychology Have a Role?.
Amonoo, Hermioni L. MD, MPP 1,2,3,; El-Jawahri, Areej MD 3,4,; Deary, Emma C. BA 2; Traeger, Lara N. PhD 3,5; Cutler, Corey S. MD 3,6,; Antin, Joseph A. MD 3,6,; Huffman, Jeff C. MD 3,5; Lee, Stephanie J. MD 7,
doi : 10.1200/JCO.21.02507
Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
Lipsyc-Sharf, Marla MD 1,2; de Bruin, Elza C. PhD 3,; Santos, Katheryn BS 1; McEwen, Robert PhD 3,; Stetson, Daniel MS 4,; Patel, Ashka BS 1; Kirkner, Gregory J. MPH 1; Hughes, Melissa E. MSc 1; Tolaney, Sara M. MD, MPH 1,2,; Partridge, Ann H. MD, MPH 1,2,; Krop, Ian E. MD, PhD 1,2,5,; Knape, Charlene MT 6,; Feger, Ute PhD 6,; Marsico, Giovanni PhD 7,; Howarth, Karen PhD 7,; Winer, Eric P. MD 1,2,5,; Lin, Nancy U. MD 1,2,; Parsons, Heather A. MD, MPH 1,2,,
doi : 10.1200/JCO.22.00908
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Zhang, Yuan MD, PhD 1; Chen, Lei MD, PhD 1; Hu, Guo-Qing MD 2; Zhang, Ning MD 3; Zhu, Xiao-Dong MD, PhD 4; Yang, Kun-Yu MD 5; Jin, Feng MD 6; Shi, Mei MD, PhD 7; Chen, Yu-Pei MD 1; Hu, Wei-Han MD 1; Cheng, Zhi-Bin MD 8; Wang, Si-Yang MD 9; Tian, Ye MD 10; Wang, Xi-Cheng MD 11; Sun, Yan MD, PhD 12; Li, Jin-Gao MD 13; Li, Wen-Fei MD, PhD 1; Li, Yu-Hong MD 14; Mao, Yan-Ping MD, PhD 1; Zhou, Guan-Qun MD, PhD 1; Sun, Rui MD 1; Liu, Xu MD, PhD 1; Guo, Rui MD, PhD 1; Long, Guo-Xian MD, PhD 2; Liang, Shao-Qiang MD 3; Li, Ling MD, PhD 4; Huang, Jing MD, PhD 5; Long, Jin-Hua MD 6; Zang, Jian MD 7; Liu, Qiao-Dan MD, PhD 9; Zou, Li MD, PhD 10; Su, Qiong-Fei MD 11; Zheng, Bao-Min MD, PhD 12; Xiao, Yun MD 13; Guo, Ying PhD 15; Han, Fei MD, PhD 1; Mo, Hao-Yuan MD 16; Lv, Jia-Wei MD 1; Du, Xiao-Jing MD, PhD 1; Xu, Cheng MD, PhD 1; Liu, Na MD, PhD 1; Li, Ying-Qin MD, PhD 1; Xie, Fang-Yun MD 1; Sun, Ying MD, PhD 1; Ma, Jun MD 1,; Tang, Ling-Long MD, PhD 1,
doi : 10.1200/JCO.22.00327
Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study.
Heesterbeek, Catharina J. MD 1; Aukema, Sietse M. MD, PhD 2; Galjaard, Robert-Jan H. MD, PhD 3; Boon, Elles M.J. PhD 4; Srebniak, Malgorzata I. PhD 3; Bouman, Katelijne MD 5; Faas, Brigitte H.W. PhD 6; Govaerts, Lutgarde C.P. MD, PhD 3; Hoffer, Mariette J.V. PhD 7; den Hollander, Nicolette S. MD, PhD 7; Lichtenbelt, Klaske D. MD, PhD 8; van Maarle, Merel C. MD, PhD 9; van Prooyen Schuurman, Lisanne MSc 3,10; van Rij, Maartje C. MD, PhD 6; Schuring-Blom, G. Heleen PhD 8; Stevens, Servi J.C. PhD 2; Tan-Sindhunata, Gita MD 4; Zamani Esteki, Masoud PhD 2,11; de Die-Smulders, Christine E.M. MD, PhD 2; Tjan-Heijnen, Vivianne C.G. MD, PhD 1,; Henneman, Lidewij PhD 4; Sistermans, Erik A. PhD 4; Macville, Merryn V.E. PhD 2,,; The Dutch NIPT Consortium
doi : 10.1200/JCO.21.02260
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial.
Li, Ning MD 1; Zhang, Youzhong PhD 2; Wang, Jing MD 3; Zhu, Jianqing MD 4; Wang, Li MB 5; Wu, Xiaohua MD 6; Yao, Desheng PhD 7; Wu, Qiang PhD 8; Liu, Jihong PhD 9; Tang, Junying PhD 10; Yin, Rutie PhD 11; Lou, Ge PhD 12; An, Ruifang MD 13; Zhang, Guonan MB 14; Xia, Xiaoping MM 15; Li, Qingshui MD 16; Zhu, Yaping PhD 17; Zheng, Hong PhD 18; Yang, Xinfeng AC 19; Hu, Yuanjing PhD 20; Zhang, Xin PhD 21; Hao, Min PhD 22; Huang, Yi MM 23; Lin, Zhongqiu PhD 24; Wang, Dong BS 25; Guo, Xiaoqing PhD 26; Yao, Shuzhong PhD 27; Wan, Xiaoyun PhD 28; Zhou, Huaijun PhD 29; Yao, Liangqing PhD 30; Yang, Xielan MM 31; Cui, Heng MD 32; Meng, Yuanguang PhD 33; Zhang, Songling PhD 34; Qu, Jing MM 35,; Zhang, Ben MS 35,; Zou, Jianjun PhD 35,; Wu, Lingying MD, PhD 1,
doi : 10.1200/JCO.21.01511
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled, Samer K. MD 1,; Claes, Kathleen MD, PhD 2,3,; Goh, Yeow Tee MBBS, MMed 4,; Kwong, Yok Lam MD 5,; Leung, Nelson MD 6,; Mendrek, Wlodzimierz MD 7,; Nakamura, Ryotaro MD 1,; Sathar, Jameela MD 8,; Ng, Edmund PhD 9,; Nangia, Narinder PhD 10,; Whitaker, Steve MD 10,; Rambaldi, Alessandro MD 11,12,,; for the OMS721-TMA-001 Study Group Members
doi : 10.1200/JCO.21.02389
Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience.
Maron, Steven B. MD, MSc 1,2,,; Moya, Stephanie BS 3; Morano, Federica MD 4,; Emmett, Matthew J. MD 5; Chou, Joanne F. PhD 6; Sabwa, Shalom BS 1; Walch, Henry MS 7,8,6; Peterson, Bryan BS 3; Schrock, Alexa B. PhD 9,; Zhang, Liangliang PhD 9,; Janjigian, Yelena Y. MD 1,2,; Chalasani, Sree MD 1; Ku, Geoffrey Y. MD 1,2,; Disel, Umut MD 10; Enzinger, Peter MD 11,; Uboha, Nataliya MD, PhD 12,; Kato, Shumei MD 13,; Yoshino, Takayuki MD, PhD 14,; Shitara, Kohei MD 14,; Nakamura, Yoshiaki MD 14,; Saeed, Anwaar MD 15,; Kasi, Pashtoon M. MD, MS 16,; Chao, Joseph MD 17,; Lee, Jeeyun MD 18,; Capanu, Marinela PhD 6; Wainberg, Zev MD 19,; Petty, Russell MB, PhD 20,; Pietrantonio, Filippo MD 4,; Klempner, Samuel J. MD 5,; Catenacci, Daniel V.T. MD 3,
doi : 10.1200/JCO.21.02453
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Joffe, Johnathan K. MBBS, MD 1; Cafferty, Fay H. PhD 2,; Murphy, Laura PhD 2; Rustin, Gordon J.S. MBBS, MSc, MD 3,; Sohaib, Syed A. BSc, MBBS 4,; Gabe, Rhian PhD 5; Stenning, Sally P. MSc 2; James, Elizabeth MSc 2; Noor, Dipa MSc 2; Wade, Simona BSc 2; Schiavone, Francesca PhD 2; Swift, Sarah MRCP 1; Dunwoodie, Elaine MBChB, MRCP, MD 1; Hall, Marcia MBBS PhD 3,6,; Sharma, Anand MBBS, MD 3; Braybrooke, Jeremy BSc, BM, PhD 7,; Shamash, Jonathan MBChB, MD 8,; Logue, John MB MRCP 9; Taylor, Henry H. BSc, MBBS, MRCP 10,; Hennig, Ivo MD, PhD 11,; White, Jeff MBChB, DM 12; Rudman, Sarah BSc(Hons), PhD, MBBS 13,; Worlding, Jane BSc, BM, MRCP 14; Bloomfield, David MBBS, MRCP, MA 15; Faust, Guy MBBS 16,; Glen, Hilary MBChB, MSc, PhD 17,; Jones, Rachel MBChB, MD 18,; Seckl, Michael PhD 19,; MacDonald, Graham MBChB, MRCP 20,; Sreenivasan, Thiagarajan MBBS, MRCP(Edin) 21,22; Kumar, Satish MD 23; Protheroe, Andrew PhD 24,; Venkitaraman, Ramachandran MD 25; Mazhar, Danish PhD 26; Coyle, Victoria MBBCh, BAO, PhD 27,; Highley, Martin MD 28; Geldart, Tom MBBS, BSc 29,; Laing, Robert MBBS, MRCP 30,; Kaplan, Richard S. MD 2,; Huddart, Robert A. PhD, MA(Oxon), MBBS, MRCP 4,; on behalf of the TRISST Trial Management Group and Investigators
doi : 10.1200/JCO.21.01199
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Gounder, Mrinal M. MD 1,,; Razak, Albiruni Abdul MB 2,; Somaiah, Neeta MD 3,; Chawla, Sant MD 4,; Martin-Broto, Javier MD 5,; Grignani, Giovanni MD 6,; Schuetze, Scott M. MD 7,; Vincenzi, Bruno MD 8,; Wagner, Andrew J. MD 9,; Chmielowski, Bartosz MD 10,; Jones, Robin L. MD 11,; Riedel, Richard F. MD 12,; Stacchiotti, Silvia MD 13,; Loggers, Elizabeth T. MD 14,; Ganjoo, Kristen N. MD 15,; Le Cesne, Axel MD 16,; Italiano, Antoine MD 17,; Garcia del Muro, Xavier MD 18,; Burgess, Melissa MD 19,; Piperno-Neumann, Sophie MD 20,; Ryan, Christopher MD 21,; Mulcahy, Mary F. MD 22; Forscher, Charles MD 23,; Penel, Nicolas MD 24; Okuno, Scott MD 25; Elias, Anthony MD 26,; Hartner, Lee MD 27; Philip, Tony MD 28,; Alcindor, Thierry MD 29,; Kasper, Bernd MD 30,; Reichardt, Peter MD 31,; Lapeire, Lore MD 32; Blay, Jean-Yves MD 33,; Chevreau, Christine MD 34,; Valverde Morales, Claudia Maria MD 35,; Schwartz, Gary K. MD 36,; Chen, James L. MD 37,; Deshpande, Hari MD 38,; Davis, Elizabeth J. MD 39,; Nicholas, Garth MD 40; Groschel, Stefan MD 41; Hatcher, Helen PhD 42; Duffaud, Florence MD 43,; Herraez, Antonio Casado MD 44,; Beveridge, Roberto Diaz MD 45; Badalamenti, Giuseppe MD 46; Eriksson, Mikael MD 47,; Meyer, Christian MD 48,; von Mehren, Margaret MD 49,; Van Tine, Brian A. MD 50,; Gotze, Katharina MD 51; Mazzeo, Filomena MD 52; Yakobson, Alexander MD 53; Zick, Aviad MD 54,; Lee, Alexander MD 55,; Gonzalez, Anna Estival MD 56,; Napolitano, Andrea MD 8; Dickson, Mark A. MD 1,; Michel, Dayana MD 57,; Meng, Changting MD 57,; Li, Lingling PhD 57; Liu, Jianjun MS 57,; Ben-Shahar, Osnat PhD 57,; Van Domelen, Dane R. PhD 57,; Walker, Christopher J. PhD 57,; Chang, Hua PhD 57,; Landesman, Yosef PhD 57,; Shah, Jatin J. MD 57,; Shacham, Sharon PhD 57,; Kauffman, Michael G. MD 57,; Attia, Steven DO 58,
doi : 10.1200/JCO.21.01829
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.
Ligibel, Jennifer A. MD 1; Bohlke, Kari ScD 2; May, Anne M. PhD 3; Clinton, Steven K. MD, PhD 4,; Demark-Wahnefried, Wendy PhD, RD 5; Gilchrist, Susan C. MD, MS 6,; Irwin, Melinda L. PhD, MPH 7; Late, Michele 8,; Mansfield, Sami BA 9; Marshall, Timothy F. PhD, MS 10,; Meyerhardt, Jeffrey A. MD, MPH 1,; Thomson, Cynthia A. PhD, RD 11; Wood, William A. MD, MPH 12,; Alfano, Catherine M. PhD 13
doi : 10.1200/JCO.22.00687
Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?.
Fallet, Vincent MD; Sanchis-Borja, Mateo MD; Benusiglio, Patrick R. MD; Cadranel, Jacques PhD
doi : 10.1200/JCO.22.00488
Reply to V. Fallet et al.
Li, Shuai MD, PhD; Silvestri, Valentina PhD; Rebbeck, Timothy R. PhD; Neuhausen, Susan L. PhD; Hopper, John L. PhD; Nielsen, Henriette Roed PhD; Ottini, Laura MD; Antoniou, Antonis C. PhD; on behalf of the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
doi : 10.1200/JCO.22.00782
Venous Thromboprophylaxis in Surgical Oncology Patients: The Importance of Risk Assessment in the Context of Limited Evidence.
Snyder, Rebecca A. MD, MPH; O'Reilly, Eileen M. MD
doi : 10.1200/JCO.21.02935
Reply to R.A. Snyder et al.
Klemen, Nicholas D. MD; Feingold, Paul L. MD; Hashimoto, Barry PhD
doi : 10.1200/JCO.22.00320
Journal Honors Patrick Reville, MD, MPH, As Recipient of the 2022 Journal of Clinical Oncology Young Investigator Award.
Boyter, Aislinn K. MS 1,
doi : 10.1200/JCO.22.01270
